Premium
Response to brodalumab and ixekizumab, anti‐interleukin‐17‐receptor antibodies for psoriasis: a critical appraisal
Author(s) -
Leonardi C.
Publication year - 2012
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.12027
Subject(s) - ixekizumab , medicine , psoriasis , critical appraisal , dermatology , immunology , secukinumab , psoriatic arthritis , alternative medicine , pathology